WCN25-3889 CLINICAL PROFILE OF RENAL ALLOGRAFT RECIPIENTS SWITCHED TO MTOR INHIBITOR-BASED REGIMEN FROM TACROLIMUS AND MYCOPHENOLATE BASED REGIMENS: A SINGLE-CENTER RETROSPECTIVE OBSERVATIONAL STUDY - Likhita Vuyyuru; Santosh Varughese; Jeethu Joseph Eapen; Nisha Jose; Vinoi George David; Suceena Alexander; Athul Thomas; Selvin Sundar Raj Mani; Joseph Johny; Chilaka Rajesh (Kidney International Reports)